SCHEMBL5835316

SCHEMBL5835316

COc1ccc(Br)cc1S(=O)(=O)Nc1ccc(Cl)c(OC2CCN(C)C2)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 12/20 0.78
TRIM24 O15164 1/20 0.49
ALPL P05186 2/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
ERBB2 P04626 1/20 0.47
EPHA2 P29317 1/20 0.47
KDR P35968 1/20 0.47
EPHB4 P54760 1/20 0.47
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
HTR1A P08908 1/20 0.45
CYP2D6 P10635 1/20 0.45
DRD2 P14416 1/20 0.45
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835310 1.00 UTS2R (0.78) UTS2RTRIM24ALPLALDH1A1LMNA
SCHEMBL8342419 0.90 UTS2R (0.75) UTS2RTRIM24ALPLALDH1A1LMNA
SCHEMBL8342806 0.90 UTS2R (0.73) UTS2RTRIM24ALDH1A1LMNAMEN1
SCHEMBL29405635 0.88 UTS2R (1.00) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL5835315 0.88 UTS2R (1.00) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL5835362 0.88 UTS2R (1.00) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL5835393 0.88 UTS2R (1.00) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL5835494 0.88 UTS2R (0.70) UTS2RALDH1A1LMNAMEN1MAPT
SCHEMBL5835495 0.88 UTS2R (0.70) UTS2RALDH1A1LMNAMEN1MAPT
Hydrochloric Acid SCHEMBL5841993 0.87 UTS2R (0.82) UTS2RALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7026349-B2 Sulfonamides SMITHKLINE BEECHAM CORPORATION (US) 2006-04-11 US claimed
US-7026349-B2 Sulfonamides SMITHKLINE BEECHAM CORPORATION (US) 2006-04-11 US disclosed
EP-1385507-A4 SULFONAMIDES SMITHKLINE BEECHAM CORP (US) 2005-11-23 EP disclosed
US-20040152906-A1 Sulfonamides SHELL OIL COMPANY 2004-08-05 US disclosed
EP-1385507-A1 SULFONAMIDES SmithKline Beecham Corporation (US) 2004-02-04 EP disclosed
WO-2002089792-A1 SULFONAMIDES SMITHKLINE BEECHAM CORPORATION (US) 2002-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152906-A1 Sulfonamides UTS2R, PRSS2, STS UTS2R 1/4885TRIM24 4248/4885ALPL 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.